2026. Selectivity Barriers in the Therapeutic Target Validation of β-Secretase-1 in the Pathogenesis of Alzheimer’s Disease: Review Article. Journal of Pharma Insights and Research. 4, 3 (Jun. 2026), 066–098. DOI:https://doi.org/10.69613/jvyw7v28.